Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed…

Overview of attention for article published in Cancer Management and Research, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,568 followers.

Characteristics of real-world patients with high-risk BRAFV | CMAR @DovePress https://t.co/22wBNFjAPR

Reply Repost Favourite